Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Minority Interest (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Minority Interest for 12 consecutive years, with -$254000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Minority Interest changed 0.0% year-over-year to -$254000.0, compared with a TTM value of -$254000.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of -$254000.0, changed 0.0% over the prior year.
  • Minority Interest was -$254000.0 for Q3 2025 at Lisata Therapeutics, roughly flat from -$254000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at -$254000.0 in Q1 2023 and bottomed at -$254000.0 in Q1 2023.
  • Average Minority Interest over 3 years is -$254000.0, with a median of -$254000.0 recorded in 2023.
  • Peak annual rise in Minority Interest hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Minority Interest stood at -$254000.0 in 2023, then changed by 0.0% to -$254000.0 in 2024, then changed by 0.0% to -$254000.0 in 2025.
  • Business Quant data shows Minority Interest for LSTA at -$254000.0 in Q3 2025, -$254000.0 in Q2 2025, and -$254000.0 in Q1 2025.